Title : Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms - Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__
Title : Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms - Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__